Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

26.22
+0.15000.58%
Volume:137.08K
Turnover:3.58M
Market Cap:1.20B
PE:11.55
High:26.42
Open:26.04
Low:25.92
Close:26.07
52wk High:41.13
52wk Low:20.39
Shares:45.95M
Float Shares:34.80M
Volume Ratio:0.62
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.27
EPS(LYR):3.29
ROE:14.84%
ROA:6.74%
PB:1.55
PE(LYR):7.96

Loading ...

Stock Track | Amphastar Pharmaceuticals Soars 6.54% on Exclusive Licensing Deal and Analyst Upgrade

Stock Track
·
Aug 12

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
Aug 12

Stock Track | Amphastar Pharmaceuticals Soars 5.63% Pre-market on Exclusive Licensing Deal and Analyst Upgrade

Stock Track
·
Aug 12

Needham Upgrades Amphastar Pharmaceuticals to Buy From Hold, Price Target is $36

MT Newswires Live
·
Aug 12

BRIEF-Amphastar Pharmaceuticals Enteres License Agreement With Nanjing Anji Biotechnology

Reuters
·
Aug 12

Amphastar Pharmaceuticals Inc : Needham Raises to Buy From Hold

THOMSON REUTERS
·
Aug 12

Amphastar Pharmaceuticals Inc - to Pay up to $267 Mln in Milestone Payments - SEC Filing

THOMSON REUTERS
·
Aug 12

Amphastar Pharmaceuticals Inc - on August 8, Entered License Agreement With Nanjing Anji Biotechnology - SEC Filing

THOMSON REUTERS
·
Aug 12

Amphastar Pharmaceuticals Secures Exclusive Licensing Deal with Anji for Innovative Peptide Therapies in Oncology and Ophthalmology

Reuters
·
Aug 12

Stock Track | Amphastar Pharmaceuticals Soars 9.26% on FDA Approval for Generic Iron Sucrose Injection

Stock Track
·
Aug 11

Stock Track | Amphastar Pharmaceuticals Soars 8.81% Pre-market on FDA Approval for Generic Iron Sucrose Injection

Stock Track
·
Aug 11

Stock Track | Amphastar Pharmaceuticals Soars 8.81% Pre-market on FDA Approval for Generic Iron Sucrose Injection

Stock Track
·
Aug 11

Amphastar Pharmaceuticals Inc -Announces FDA Approval for Iron Sucrose Injection, Usp

THOMSON REUTERS
·
Aug 11

Amphastar Pharmaceuticals Secures FDA Approval for Generic Iron Sucrose Injection for Treating Iron Deficiency Anemia

Reuters
·
Aug 11

Stock Track | Amphastar Pharmaceuticals Soars 11.79% as Q2 Earnings Surpass Expectations

Stock Track
·
Aug 08

Stock Track | Amphastar Pharmaceuticals Soars 5.41% on Earnings Beat Despite Revenue Dip

Stock Track
·
Aug 08

Amphastar Pharmaceuticals Q2 2025 Earnings Call Summary and Q&A Highlights: Baqsimi Drives Growth Amid Competitive Pressures

Earnings Call
·
Aug 08

Stock Track | Amphastar Pharmaceuticals Soars 6.15% After-Hours on Q2 Earnings Beat and Expansion Plans

Stock Track
·
Aug 08

Amphastar Pharma Q2 Adj. EPS $0.85 Beats $0.76 Estimate, Sales $174.414M Beat $174.249M Estimate

Benzinga
·
Aug 08

Director Floyd F. Petersen Reports Disposal of Common Shares of Amphastar Pharmaceuticals Inc

Reuters
·
Aug 05